HK1189591A1 - Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22- - Google Patents

Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22-

Info

Publication number
HK1189591A1
HK1189591A1 HK14102704.7A HK14102704A HK1189591A1 HK 1189591 A1 HK1189591 A1 HK 1189591A1 HK 14102704 A HK14102704 A HK 14102704A HK 1189591 A1 HK1189591 A1 HK 1189591A1
Authority
HK
Hong Kong
Prior art keywords
tivdroxyphenoxy
diphenylhexanamide
azetidi
methyl
hydrochloride salt
Prior art date
Application number
HK14102704.7A
Other languages
English (en)
Chinese (zh)
Inventor
．格羅索普
．詹姆斯
Original Assignee
輝瑞有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39591485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1189591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 輝瑞有限公司 filed Critical 輝瑞有限公司
Publication of HK1189591A1 publication Critical patent/HK1189591A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK14102704.7A 2007-03-16 2014-03-18 Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22- HK1189591A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89516307P 2007-03-16 2007-03-16

Publications (1)

Publication Number Publication Date
HK1189591A1 true HK1189591A1 (en) 2014-06-13

Family

ID=39591485

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14102704.7A HK1189591A1 (en) 2007-03-16 2014-03-18 Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22-

Country Status (24)

Country Link
US (1) US8263583B2 (de)
EP (1) EP2125714B1 (de)
JP (1) JP4277051B2 (de)
KR (1) KR101120227B1 (de)
CN (2) CN101641327A (de)
AR (1) AR065714A1 (de)
AT (1) ATE512132T1 (de)
AU (1) AU2008247095B2 (de)
BR (1) BRPI0808413A2 (de)
CA (1) CA2678683C (de)
CY (1) CY1111701T1 (de)
DK (1) DK2125714T3 (de)
ES (1) ES2364727T3 (de)
HK (1) HK1189591A1 (de)
IL (1) IL200403A (de)
MX (1) MX2009009952A (de)
NZ (1) NZ579056A (de)
PL (1) PL2125714T3 (de)
PT (1) PT2125714E (de)
RU (1) RU2422439C2 (de)
SI (1) SI2125714T1 (de)
TW (1) TWI348907B (de)
WO (1) WO2008135819A1 (de)
ZA (1) ZA200906462B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201290295A1 (ru) 2009-11-23 2013-01-30 Палатин Текнолоджиз, Инк. Специфичные к рецептору меланокортина-1 линейные пептиды
BR112012011787B1 (pt) 2009-11-23 2022-03-03 Palatin Technologies, Inc Peptídeo cíclico e composição farmacêutica
EP2578570A1 (de) 2011-10-07 2013-04-10 Almirall, S.A. Neues Verfahren zur Herstellung von 5-(2-{[6-(2,2-Difluor-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxychinolin-2(1H)-on mittels neuen Synthesezwischenstoffen
EP2641900A1 (de) 2012-03-20 2013-09-25 Almirall, S.A. Neuartige polymorphe Kristallformen von 5-(2-{[6-(2,2-difluor-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxychinolin-2(1H)-on, Heminapadisylat als Agonist des beta2-adrenergen Rezeptors
EP3596046A1 (de) * 2017-03-15 2020-01-22 Mylan Laboratories Ltd. Neuartige polymorphe von (5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid-hydrochlorid
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
US11479770B2 (en) 2017-10-05 2022-10-25 Fulcrum Therapeutics, Inc. Use of p38 inhibitors to reduce expression of DUX4
EP3990091A4 (de) * 2019-06-25 2023-07-12 Mylan Laboratories Ltd. Verfahren und zwischenprodukte zur herstellung von hydrochloridsalz von 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamid
WO2021260441A1 (en) * 2020-06-26 2021-12-30 Mylan Pharma Uk Limited Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
CN113577059B (zh) * 2021-08-02 2022-05-20 山东大学齐鲁医院(青岛) 一种用于小儿哮喘的活性药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733209B2 (en) * 1996-12-02 2001-05-10 Kyorin Pharmaceutical Co. Ltd. Novel n-substituted pyrrolidine derivatives and process for preparing the same
JPH11100366A (ja) * 1997-09-29 1999-04-13 Kyorin Pharmaceut Co Ltd 新規ｎ−置換環状アミン誘導体及びその製造法
ME01106B (me) * 2005-09-21 2013-03-20 Pfizer Ltd Derivati karboksamida kao antagonisti muskarinskih receptora
CA2664057A1 (en) * 2006-09-22 2008-03-27 Pfizer Limited Azetidine derivatives as muscarinic receptor antagonists

Also Published As

Publication number Publication date
CA2678683A1 (en) 2008-11-13
US20100113409A1 (en) 2010-05-06
WO2008135819A1 (en) 2008-11-13
IL200403A0 (en) 2010-04-29
ATE512132T1 (de) 2011-06-15
AU2008247095A1 (en) 2008-11-13
CA2678683C (en) 2012-05-15
CN103351367A (zh) 2013-10-16
ZA200906462B (en) 2010-06-30
SI2125714T1 (sl) 2011-10-28
US8263583B2 (en) 2012-09-11
JP4277051B2 (ja) 2009-06-10
TW200904408A (en) 2009-02-01
ES2364727T3 (es) 2011-09-13
DK2125714T3 (da) 2011-07-25
RU2422439C2 (ru) 2011-06-27
EP2125714A1 (de) 2009-12-02
WO2008135819A8 (en) 2009-08-27
PT2125714E (pt) 2011-07-14
CN103351367B (zh) 2015-06-10
JP2009001543A (ja) 2009-01-08
BRPI0808413A2 (pt) 2014-07-15
EP2125714B1 (de) 2011-06-08
RU2009134512A (ru) 2011-03-20
IL200403A (en) 2014-08-31
KR20090110944A (ko) 2009-10-23
CY1111701T1 (el) 2015-10-07
AR065714A1 (es) 2009-06-24
MX2009009952A (es) 2009-10-08
KR101120227B1 (ko) 2012-03-20
PL2125714T3 (pl) 2011-10-31
TWI348907B (en) 2011-09-21
CN101641327A (zh) 2010-02-03
AU2008247095B2 (en) 2012-12-13
NZ579056A (en) 2011-07-29

Similar Documents

Publication Publication Date Title
HK1189591A1 (en) Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidi-1-v-5-methyl-2 2- diphenylhexanamide 5-[3-(3-)-1-]-5--22-
IL197420A0 (en) Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-
IL212186A0 (en) Fungicidal heterocyclic compounds
ZA201006511B (en) Heterocyclic compound
EP2269990A4 (de) Heterocyclische verbindung
EP2192838A4 (de) Heterocyclische nekroptose-hemmer
ZA201103887B (en) Isoxazole derivatives for use as fungicides
ZA201006505B (en) Novel heterocyclic compounds and uses thereof
HK1148283A1 (en) Heterocyclic derivatives
EP2202223A4 (de) Heterocyclische verbindung
IL200329A0 (en) 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
GB0700194D0 (en) Humanisation of animals
EP2196459A4 (de) 5-gliedrige heterocyclische verbindung
PL2254887T3 (pl) Pochodne oksazolidynonu
IL195158A0 (en) Novel heterocyclic compounds
EP2210876A4 (de) Heterocyclische verbindung
EP2295406A4 (de) Heterocyclische verbindung
HRP20150932T1 (en) Heterocyclic compounds
ZA201002580B (en) Heterocyclic derivatives
GB0612508D0 (en) Crystalline duloxetine hydrochloride
GB0700830D0 (en) Crystalline duloxetine hydrochloride
GB0612506D0 (en) Crystalline duloxetine hydrochloride
GB0921210D0 (en) Novel heterocyclic derivatives
EP2189445A4 (de) Fünfgliedrige heterocyclische verbindung
GB0619308D0 (en) Heterocyclic compounds